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Interactions involving tumor cells and the extracellular
matrix (ECM) strongly influence tumor development,
including head and neck tumors, affecting cell proliferation
and survival as well as the ability to migrate beyond the
original location into other tissues to form metastases. These
cell migration is often facilitated by partial destruction of
the surrounding ECM, which is catalyzed by matrix
metalloproteinases (MMPs), a family of more than 20
endopeptidases that is controlled by regulated expression
of specific inhibitors (TIMPs). Several studies of ECM and
MMPs markers have provided additional diagnostic and
prognostic information in head and neck carcinomas. In this
review, we are considering the role of ECM and MMPs in
tumor progression, emphasizing its proteolytic contributors
to this process, and interactions between several members
of ECM providing substrate to regulation of this process.
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INTRODUCTION
Squamous cell carcinoma is the most common head
and neck malignant neoplasm, which is characterized by
presenting aggressive clinical course and significant likelihood
of developing metastases, especially for neck lymph nodes 1.
Carcinogenesis of tumors of the head and neck is a
process of multiple steps, in which there are genetic
affections that leads to deregulation of cell metabolism.
Aggressiveness of tumors is related to many different factors,
among which we can refer to level of histological malignancy,
side of lesion, degree of adjacent tissue involvement,
presence of metastasis at diagnosis and anatomical location
of tumor. One of the main factors that influence prognosis
of these neoplasms is presence of metastasis of neck lymph
nodes or distant organs. The assessment of factors that
influence this process is important for better knowing about
tumor behavior and development of anti-cancer therapies.
Tumor growth results from imbalance between cell
proliferation and apoptosis and it is influenced by
angiogenesis, whereas metastatic potential is influenced by
affections to cell-cell and cell-matrix interactions.
Extracellular matrix is a structure consisted of many
proteins and polysaccharides distributed differently among
the many different tissues of the body. This environment
provides appropriate conditions for growth and cell
differentiation, favoring the survival of tissues.
Basic constitution of matrix is fibrous proteins such as
collagen and elastin, and elongated glucoproteins such as
fibronectin and laminin, whose function is to provide cell-
matrix adhesion, in addition to glucoaminoglican and
proteoglican that form a bed of gel, in which there all the
constituents of the matrix 2.
The role of extracellular matrix in the tumor
microenvironment is not limited only to acting as a physical
barrier to neoplasm, but it also works as a reservoir for ligant
proteins and growth factors that influence its behavior 3.
Degeneration of matrix is a key event in invasion
and metastasis of tumors. This degradation is caused by
proteolytic enzymes, denominated metalloproteinase, which
act by disorganizing the matrix through a process that affects
cell-cell and cell-matrix interactions.
The present study aims at revising the role of
extracellular matrix in head and neck carcinoma, comprising
the mechanisms that take place during its degradation and
favoring the process of invasion and metastasis, which are
the main factors that influence prognosis and survival of
patients with this neoplasm.
LITERATURE REVIEW
Extracellular matrix (ECM): Structure and Function
Animal and vegetable tissues are not formed only by
cells, but also by extracellular space filled with a complex of
fibrous and proteic components named extracellular matrix
(ECM)2,4. It comprises varied proportions of proteins and
polysaccharides, organized in networks, which are
responsible for the morphological, functional and pathological
diversity of tissues, providing the appropriate substrate for
growth and differentiation of varied cell types 4, 5.
Among the constituents of ECM we can include many
different types of macromolecules (proteoglicans and
glycosaminoglicans) in addition to fibrous proteins of collagen
and elastin, both with structural and functional aspects, and
as adhesive glucoproteins such as laminin, tenascin and
fibronectin 6.
ECM is classified as interstitial matrix, which comprises
the whole space existing between mesenchymal cells and
basal membrane, which is represented by specialized
extracellular matrix in laminar shape 2, 7. The interaction
between the protein and fibrous complex, soluble proteins
and surface receptors influence many cell properties,
including migration, proliferation, stages of differentiation
and apoptosis 4.
Interactions and links between cells and ECM
components are conducted by specific receptors named
integrins, which are transmembrane proteins, with
extracellular domain that is attached to ECM components
and a cytoplasmatic component linked to the cytoskeleton
portion formed of actin 8,9.
ECM x Cancer
It has been clearly established in the literature that
tumor stroma is directly related with biological behavior of
neoplasm, despite the fact that for a long time, neoplasm
cells were the main focus of cancer studies 10.
The capability malignant cells have to destroy basal
membrane and the other components of ECM has been
related to invasive potential of this neoplasm 11. Recent
studies conducted using markers of ECM components such
as enzymes related to its degradation (MMP) have contributed
to the understanding of the biological and clinical behavior
of head and neck carcinoma.
In the studies by Thomas et al.12 the increase in
production of these enzymes was associated with metastatic
phenotype and it was invasive in many tumors, and
consequently, with tumor behavior and prognosis.
ECM influences the behavior of neoplasms through
many mechanisms related to proliferation, progression and
tumor invasion. For example, local invasion and development
of metastases in head and neck carcinoma are directly
associated with extracellular matrix, including basal
membrane affection and induction of production of many
ECM proteins 13.
When head and neck squamous cell carcinoma are in
development, adjacent tissue suffers many variations such
as stroma lysis with degradation of ECM, a fact considered to
be the preparation for tumor invasion 12, 14. Additionally, such
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structure may have a more active role during carcinogenesis
to induce angiogenesis and production of growth factors,
stimulating proliferation of neoplastic cells 10,15.
During the process of tumor invasion, neoplastic cells
cross two types of matrix (basal membrane and interstitial
stroma) and biochemical reactions between normal cells and
ECM influence the process of tumor invasion in neoplasm 7,16.
According to Sherstha et al.17 ECM constituents
contribute directly or indirectly to the tumor process, owing
to the fact that the structure has potentially anti-adhesive
components, modulators of adhesion, proliferation and cell
migration. Additionally, the authors reported that ECM may
regulate cell behavior using different mechanisms: first
through composition of proteins in a specific tissue and
second in synergic interactions between growth factors and
adhesion molecules or cell receptors that mediate adhesion
of components.
Many studies using markers for different constituents
of EMC were conducted to clarify the role of this structure in
the process of carcinogenesis and progression of head and
neck tumors.
Collagen represents a family of characteristic proteins
with over 20 known types, present in all multicellular animals,
being the most abundant components in all extracellular
matrixes 2, 18.
Some studies have demonstrated discontinuity of
different types of collagen during the process of tissue
invasion by neoplastic cells 7, 18.
Studies conducted by Becker et al.19 in normal oral
mucosa and squamous cell carcinoma highlighted that in
normal oral mucosa we can observe a significant amount of
collagen III in the subepithelial region and collagen I and II
in the deepest portions of connective tissue. In the stroma
of oral squamous cell carcinoma, authors noticed that collagen
I fibers surrounded the tumor epithelial islands and were
distributed throughout the stroma. In laryngeal tumors,
Hagedorn et al.20 detected defects of peritumor basal
membrane owing to loss of significant expressions of
collagen IV.
Intensity and quality of collagen I marking presented
a varied form in oral squamous cell carcinoma of low and
high grade malignancy in the study developed by Martins
et al.18, in which marking of this type of collagen was more
intensive in less aggressive tumors.
Laminin is another protein associated with basal
membrane that works as adhesin, binding basal cells of
epithelium to collagen IV. It has been directly related with
advanced stages of cell differentiation, being a pre-requisite
for terminal differentiation and execution of specialized
functions, by interacting with integrinins and other
components of cell surface as well as controlling cell
migration, polarization, proliferation and apoptosis 21.
According to the reports by Thorup et al.22, in poorly
differentiated oral squamous cell carcinomas there is marked
loss of laminin expression and its integrin receptors, when
compared to pre-malignant lesions and inflammatory pro-
cesses. We evidenced from Tosios et al.23 studies a tendency
to linear discontinuity of laminin and collagen IV during gra-
dual increase of dysplasia, and in areas of deep tumor invasion
more than in central or superficial tumor regions.
Berndt et al.24 associated the behavior of oral
squamous cell carcinoma with synthesis of laminin, a fact
evidenced through focus loss of basal membrane and its
deposition in the stroma immediately close to invasive
neoplastic cells.
In previous studies, Harada et al.25 found a pattern of
expression similar to laminin, collagen IV and heparan sulfate
in the invasive front of oral carcinomas and metastasis in
lymph nodes, leading to the conclusion that cell population
in deeper areas of the tumor may be determinant to the
invasive and metastatic potential of carcinomas situated in
this region.
Kannan et al.26 noticed in the oral cavity a gradual
increase of frequency of laminin discontinuity and collagen
IV from normal, hyperplastic, dysplastic epithelium to
malignant one, reporting that progressive affection of basal
membrane in malignant transformation may be an indicator
of clones of cell population with invasive phenotype, despite
the fact that it had not evidenced in the study any correlation
between distribution of laminin and collagen IV with grade
of malignancy. This trend was also previously noticed in
neck epithelial neoplasms and aerodigestive tract dysplasias
23. The reduced expression of collagen IV was also noticed
by Harada et al.25 in oral carcinomas.
In percentage terms, Haas et al.27 using
immunofluorescence technique, detected that the intensity
of laminin on the basal membrane of normal oral mucosa
was about 99 to 100%, increasing to 107 to 141% in
hyperplastic lesions, significantly reducing the front of oral
squamous cell carcinomas (35 to 74%).
As to fibronectin, an adhesive glycoprotein of ECM, it
has been suggested that its loss during carcinogenesis may
allow free migration of neoplastic cells 21,28,29. Its expression
has been related to poor prognosis of head and neck tumors,
a fact confirmed by the studies developed by Kannan et
al.18 in the normal oral mucosa and squamous cell carcino-
mas, and by Zidar et al.30 who detected gradual increase of
fibronectin on basal membranes of laryngeal squamous cell
carcinomas, detecting also expression which was inversely
proportional to density of associated inflammatory infiltrate
and level of tumor differentiation.
Intracytoplasmatic immunomarking of fibronectin was
observed in 16.7% of tongue squamous cell carcinomas,
contrarily to the lips, in Miranda31 study, which may, according
to the author, be indicative that tumor cells and not only
stromal cells may synthesize fibronectin, building up on the
basal membrane and peritumor matrix to probably facilitate
adherence and posterior migration through tumor stroma.
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Tenascin is an adhesive glycoprotein of ECM expressed
in epithelial-mesenchymal membrane during embryogenesis
and tumorgenesis 17,32. This protein had many domains of
binding, mediating cell-cell adhesion, cell migration, as well
as cell adhesion close to matrix through fibronectin binding
to proteoglicans11.
When this protein is produced by malignant
neoplastic cells, there seems to be an increase in proliferation
and migration, probably owing to the fact that it has anti-
adhesive properties, because it blocks binding of fibronectin
to cells. Such property was detected in the studies by Huang
et al.33 that described a model in which tenascin impaired
the adhesive function of fibronectin by biding to FNH13,
inhibiting the co-receptor function of sidecan-4 in the
signalization of integrins induced by fibronectin.
It has been demonstrated that its expression is
increased in many neoplastic lesions 33,34. The combination
of tenascin and other growth factors, in addition to affections
to receptors of neoplastic cells may act synergistically in the
modulation of cell growth, interfering in tumor progression,
invasive behavior and metastatic potential 17.
In some neoplasm such as breast and astrocytoma,
the high expression of tenascin was indicative of proliferative
activity and tumor aggressiveness 35, but no correlation was
observed in salivary gland tumors and some basal carcino-
mas 36.
The intracytoplasmatic presence of tenascin in the
front of invasion of tongue and jugal mucosa squamous cell
carcinoma was detected in the studies by Mori et al.37. Yoshida
et al.34 observed significant increase of expression of tenascin
in tumor stroma cells of laryngeal carcinoma especially around
neoplastic cell nests, leading the authors to the conclusion
that tenascin produced in tumor cells could be involved in
intraepithelial extension and invasion of connective tissue,
through high mitotic activity and migration of cancer cells.
Upon studying hypopharynx and laryngeal carcino-
mas, Juhász et al.11 noticed that in advanced tumors tenascin
was not expressed only in tumor-host interface, but also in
the blood vessels, both in stroma and tumor parenchyma. In
this study, they confirmed that accumulation of tenascin in
the blood vessels could be considered as an indicative factor
of poor prognosis of hypopharynx and larynx carcinomas.
Miranda31 analyzed the correlation of expression pattern
of many proteins in ECM, such as laminin, collagen I and IV,
fibronectin and tenascin in lower lip and tongue squamous
cell carcinoma with varied histology grading, and observed
that collagen IV and laminin were absent on the basal
membrane of neoplastic cell nests of most studied cases and
when present, marking was weak. Fibronectin was
immunomarked in all studied cases and tenascin expressed
intensively on epithelial basal membrane in most studied ca-
ses, also present in peritumor stroma, predominantly with
weak intensity in the lip and moderate to strong in the tongue.
To collagen I, it was observed focal expression in both groups
of carcinoma, with weak intensity of reaction and
predominantly fibrillar and disorganized pattern. The author
suggested then that tongue squamous cell carcinomas have
greater invasive potential and more aggressive behavior when
compared to lower lip tumors.
Degradation of ECM
Degradation of ECM is an essential event in many
physiological processes such as during embryonic
development, growth and tissue repair. Conversely, its
excessive degradation may result in development of many
different pathological conditions, among which we can
include rheumatoid arthritis, osteoarthritis, and autoimmune
diseases 38. This fact is also directly related to the process of
invasion and tumor metastasis, which is the main prognostic
factor related to patients with cancer 39.
Some specific proteases known as metalloproteinase
(MMP) or matrix metalloproteinase, form an important family
of metal-dependent endopeptidase, inactively secreted with
zinc in the active site 5, 38.
There are currently at least 20 types of human MMPs,
which are grouped according to the structure and specific
substrate in: collagenase (MMP-1, -8 e 13), stromelisin,
gelatinase (MMP-2, -9) and plasma membrane-binding
metalloproteinases 12,40.
According to Curran, Murray5 and Nabeshima et al.40,
overexpression of MMPs has been evidenced and related to
prognosis in different types of carcinomas, which can be
used for the development of protein inhibiting drugs to
support anti-cancer therapy.
It is defined in the literature that tumor invasion also
suffers direct influence of the microenvironment, in which
one of the critical factors is the action of many different
proteolytic enzymes that act directly on degradation of ECM
proteins, named metalloproteinases (MMPs)41-43. These
enzymes may be produced both by tumor stroma and by
their own neoplastic cells, which may also, according to Yves
and Derderck3, interfere in the process of cell-cell adhesion
by degradation of E-caderin.
To Thomas et al.12, the increase in production of these
enzymes has been associated with invasive phenotype in
many different tumors. Such statement was confirmed in
the studies by Hong et al.1, who studied expression of MMP-
2 and -9 in oral squamous cell carcinomas and correlated
presence of MM-9 and metastatic potential of carcinoma, in
agreement with the studies by Miyajima et al.42. Davies et
al.44 also detected the presence of metalloproteinases in
cancer cells of stomach, breast, liver, and pharynx, relating
this fact to malignant potential of these cells and to poor
clinical course of these neoplasms.
Many studies developed, such as those reported by
O-Charoenrat et al.45 and O-Charoenrat et al.46, demonstrated
that expression of MMPs and its inhibitors (TIMPs) is present
in head and neck squamous cell carcinomas. In these studies,
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the authors noticed that MMPs-2, -7, -9 and –11 played an
important role in the progression and development of
metastases in these tumors.
Upon analyzing 25 non-metastatic oral squamous cell
carcinoma and 19 metastatic carcinomas using
immunohistochemical and zymography techniques, Hong
et al.1 compared expression and activity of MMPs-2 e –9 in
these groups and detected that MMP-9 would play an even
bigger role in the development of metastases than MMP-2.
Additionally, the study did not show correlation between
histological grading of carcinomas and expression of MMPs,
suggesting that histology differentiation of cancer cells does
not interfere in expression of MMPs.
Nabeshima et al.40 reported that MMP-2 and -4 are
capable of cleavage site g2 of laminin-5, leading to stimulation
of proliferation and migration of neoplastic cells. These
authors also reported that metalloproteinases interfere in
the cell-cell adhesion mechanism especially over the
complex E-caderin/b-catenin, facilitating the invasion
process.
The importance of knowing the role of ECM and MMPs
proteins in head and neck carcinomas is quite obvious, given
that they play a key role in progression and aggressiveness
of these tumors.
CLOSING REMARKS
In view of the studied literature, we observed that
ECM and MMPs, owing to their influence on many cell
functions during carcinogenesis and because they are directly
related with behavior of head and neck carcinoma, deserve
special attention when being studied, given that ECM and
its degradation represent the key element in understanding
the mechanisms involved with tumor invasion. Affections to
extracellular matrix through overexpression of tenascin or
discontinuity in collagen, fibronectin and laminin structure,
in addition to the presence of MMPs, influence the behavior
of neoplastic cells, acting over tumor growth, tissue adhesion,
invasion and metastases, which represent the main factors
indicative of prognosis and survival of patients with these
carcinomas.
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